APAC shows prominent growth, with the fastest-growing CAGR of 11.91% in the global pharmaceutical R&D outsourcing market ... are making DCTs more scalable and reliable, with companies like ICON Plc ...

Shares tumbled over 10%, leading a chip sell-off as China's new AI model prompted fresh questions on Big Tech's investments.

In the present evolving business landscape, Corporate Connect is dedicated to acknowledging and honouring organisations and ...

Baron Funds, an investment management company, released its “Baron Small Cap Fund” fourth-quarter 2024 investor letter. A ...

TD Cowen adjusted its financial outlook for ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries.

Headquartered in Dublin, Ireland, ICON Public Limited Company (NASDAQ ... we believe pharmaceutical R&D spend will continue to grow and global providers like ICON are well positioned to expand ...

Regarding infrastructure, Weil pointed to OpenAI’s $500 billion Stargate initiative, which is aimed at expanding U.S. energy and semiconductor capabilities to support AI growth. He also highlighted ...

Baron Small Cap Fund declined in Q4 2024. Who were the top contributors and detractors? Click here to find out.

The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.

Turing today announced it achieved profitability in 2024 on $300 million in annual revenue runrate (ARR), which is nearly triple the prior year and solidifies its status as one of the world's fastest ...